"Angioedemas, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT.
Descriptor ID |
D054179
|
MeSH Number(s) |
C14.907.079.500 C16.320.078 C17.800.862.945.066.500 C20.543.480.904.066.500
|
Concept/Terms |
Angioedemas, Hereditary- Angioedemas, Hereditary
- Angioneurotic Edema, Hereditary
- Angioneurotic Edemas, Hereditary
- Edema, Hereditary Angioneurotic
- Edemas, Hereditary Angioneurotic
- Hereditary Angioneurotic Edemas
- C1 Inhibitor Deficiency
- Hereditary Angioedemas
- Hereditary Angioneurotic Edema
- C1 Esterase Inhibitor Deficiency
- Angioedema, Hereditary
- Hereditary Angioedema
|
Below are MeSH descriptors whose meaning is more general than "Angioedemas, Hereditary".
Below are MeSH descriptors whose meaning is more specific than "Angioedemas, Hereditary".
This graph shows the total number of publications written about "Angioedemas, Hereditary" by people in this website by year, and whether "Angioedemas, Hereditary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 4 | 0 | 4 |
2018 | 7 | 0 | 7 |
2019 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Angioedemas, Hereditary" by people in Profiles.
-
C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development. Curr Med Chem. 2022; 29(3):467-488.
-
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1-inhibitor deficiency. Allergy. 2021 08; 76(8):2535-2543.
-
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks During COVID-19. J Investig Allergol Clin Immunol. 2021 Jul 26; 31(4):356-357.
-
COVID-19 as a trigger of acute attacks in people with hereditary angioedema. Clin Exp Allergy. 2021 07; 51(7):947-950.
-
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2021 01; 9(1):508-510.
-
Is hereditary angioedema related to an increased risk of atherosclerosis? Ann Allergy Asthma Immunol. 2019 02; 122(2):228-229.
-
Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. BioDrugs. 2019 Feb; 33(1):33-43.
-
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):2035-2038.
-
New and evolving therapies for hereditary angioedema. Allergy Asthma Proc. 2019 Jan 01; 40(1):7-13.
-
Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiency. Allergy. 2019 04; 74(4):834-840.